337 filings
Page 3 of 17
DEFA14A
ORTX
Orchard Therapeutics plc
17 Oct 23
Additional proxy soliciting materials
4:32pm
SC 13G
ORTX
Orchard Therapeutics plc
16 Oct 23
Orchard Therapeutics / Beryl Capital Management ownership change
4:01pm
DEFA14C
ORTX
Orchard Therapeutics plc
5 Oct 23
Additional information
5:26pm
DEFA14C
ORTX
Orchard Therapeutics plc
5 Oct 23
Additional information
4:48pm
DEFA14C
ORTX
Orchard Therapeutics plc
5 Oct 23
Additional information
4:45pm
DEFA14C
ORTX
Orchard Therapeutics plc
5 Oct 23
Additional information
4:43pm
DEFA14C
ORTX
Orchard Therapeutics plc
5 Oct 23
Additional information
4:40pm
DEFA14A
ORTX
Orchard Therapeutics plc
5 Oct 23
Additional proxy soliciting materials
9:07am
8-K
ORTX
Orchard Therapeutics plc
5 Oct 23
Kyowa Kirin to Acquire Orchard Therapeutics
9:05am
8-K
ORTX
Orchard Therapeutics plc
18 Sep 23
Orchard Therapeutics Announces Acceptance of Biologics License Application for OTL-200 in MLD and Receives Priority Review
7:07am
EFFECT
ORTX
Orchard Therapeutics plc
22 Aug 23
Notice of effectiveness
12:15am
424B3
ORTX
Orchard Therapeutics plc
21 Aug 23
Prospectus supplement
4:32pm
CORRESP
ORTX
Orchard Therapeutics plc
17 Aug 23
Correspondence with SEC
12:00am
UPLOAD
ORTX
Orchard Therapeutics plc
16 Aug 23
Letter from SEC
12:00am
S-8
ORTX
Orchard Therapeutics plc
10 Aug 23
Registration of securities for employees
5:04pm
S-3
ORTX
Orchard Therapeutics plc
Shelf registration
10 Aug 23
5:01pm
10-Q
2023 Q2
ORTX
Orchard Therapeutics plc
Quarterly report
10 Aug 23
4:36pm
8-K
ORTX
Orchard Therapeutics plc
3 Aug 23
Orchard Therapeutics Completes Submission of Biologics License Application for OTL-200 in MLD to U.S. FDA
7:05am
8-K
ORTX
Orchard Therapeutics plc
26 Jun 23
Resulting in $34 Million of Additional Capital
7:06am
4
Altschuler Steven
16 Jun 23
Orchard Therapeutics / Steven Altschuler ownership change
4:30pm